Yu-Min Yeh

566 total citations
16 papers, 402 citations indexed

About

Yu-Min Yeh is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yu-Min Yeh has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Yu-Min Yeh's work include Genetic factors in colorectal cancer (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Treatment and Pharmacology (4 papers). Yu-Min Yeh is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Treatment and Pharmacology (4 papers). Yu-Min Yeh collaborates with scholars based in Taiwan, United States and Malaysia. Yu-Min Yeh's co-authors include Meng‐Ru Shen, Wu‐Chou Su, Peng-Chan Lin, Jang‐Yang Chang, Daniel C. Malone, Ching‐Yuan Chang, Debbie L. Wilson, Haesuk Park, Pei-Ying Wu and Wei-Hsuan Lo-Ciganic and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yu-Min Yeh

16 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Min Yeh Taiwan	12	219	138	69	58	55	16	402
Didem Taştekin Türkiye	15	197 0.9×	185 1.3×	42 0.6×	61 1.1×	23 0.4×	66	507
Harold K. Elias United States	12	110 0.5×	236 1.7×	60 0.9×	120 2.1×	45 0.8×	28	565
Marta Derecka United States	10	176 0.8×	289 2.1×	67 1.0×	171 2.9×	33 0.6×	16	553
Xuexian Yan Singapore	7	117 0.5×	152 1.1×	96 1.4×	74 1.3×	15 0.3×	16	414
Hiroyuki Tsuruta Japan	11	195 0.9×	164 1.2×	45 0.7×	21 0.4×	26 0.5×	18	400
Wei‐Hwa Lee Taiwan	11	123 0.6×	209 1.5×	48 0.7×	24 0.4×	24 0.4×	26	464
Laura Elisa Buitrago‐Molina Germany	13	205 0.9×	235 1.7×	36 0.5×	182 3.1×	34 0.6×	23	628
Takashi Sekikawa Japan	11	165 0.8×	117 0.8×	34 0.5×	34 0.6×	27 0.5×	33	408
Y Uenoyama Japan	7	243 1.1×	221 1.6×	84 1.2×	183 3.2×	45 0.8×	8	509

Countries citing papers authored by Yu-Min Yeh

Since Specialization

Citations

This map shows the geographic impact of Yu-Min Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Min Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Min Yeh more than expected).

Fields of papers citing papers by Yu-Min Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Min Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Min Yeh. The network helps show where Yu-Min Yeh may publish in the future.

Co-authorship network of co-authors of Yu-Min Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Min Yeh. A scholar is included among the top collaborators of Yu-Min Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Min Yeh. Yu-Min Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Segal, Neil H., Maria Passhak, Eugen Kubala, et al.. (2025). Co-formulated favezelimab plus pembrolizumab versus standard-of-care in previously treated, PD-L1-positive metastatic colorectal cancer: The phase 3, randomized KEYFORM-007 study.. Journal of Clinical Oncology. 43(4_suppl). 2 indexed citations

Lin, Peng-Chan, Shang‐Hung Chen, Shao-Chieh Lin, et al.. (2021). Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer. Frontiers in Oncology. 11. 589673–589673. 9 indexed citations

Lin, Peng-Chan, et al.. (2021). Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy. BMC Cancer. 21(1). 217–217. 11 indexed citations

Yeh, Yu-Min, Chou‐Ching K. Lin, Peng-Chan Lin, et al.. (2021). Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy. Theranostics. 11(10). 4672–4687. 18 indexed citations

Chang, Ching‐Yuan, Haesuk Park, Daniel C. Malone, et al.. (2020). Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma. JAMA Network Open. 3(3). e201611–e201611. 78 indexed citations

Lee, Chung-Ta, Nan-Haw Chow, Yi-Lin Chen, et al.. (2020). Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer. Pathology - Research and Practice. 217. 153288–153288. 13 indexed citations

Yeh, Yu-Min, Yi‐Fan Chen, Yu‐Hsiang Hsu, et al.. (2020). Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy. Pain. 161(6). 1237–1254. 28 indexed citations

Wu, Pei-Ying, Pei-Fang Su, Chung-I Li, et al.. (2020). A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy. Disease Markers. 2020. 1–8. 4 indexed citations

Lin, Peng-Chan, Yu-Min Yeh, Pei-Ying Wu, et al.. (2019). Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer. Scientific Reports. 9(1). 3931–3931. 13 indexed citations

10.

Chen, Shang‐Hung, Jeng‐Kai Jiang, Ching-Wen Huang, et al.. (2019). Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol. BMC Cancer. 19(1). 640–640. 4 indexed citations

11.

Yeh, Yu-Min, Peng-Chan Lin, Keng‐Fu Hsu, et al.. (2017). The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages. Clinical Cancer Research. 23(20). 6021–6030. 18 indexed citations

12.

Chen, Yi‐Fan, Yu-Min Yeh, Pei-Ying Wu, et al.. (2017). Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy. Scientific Reports. 7(1). 45366–45366. 41 indexed citations

13.

Chang, Kung‐Chao, Wei-Chao Chang, Yao Chang, et al.. (2013). Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma. PLoS ONE. 8(11). e79863–e79863. 15 indexed citations

14.

Chang, Kung‐Chao, Yu-Chu Wang, Liang‐Yi Hung, et al.. (2013). Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Modern Pathology. 27(6). 823–831. 67 indexed citations

15.

Hsu, Tsung‐I, Szu-Yu Chen, Shih‐Ting Huang, et al.. (2012). Betulinic Acid Decreases Specificity Protein 1 (Sp1) Level via Increasing the Sumoylation of Sp1 to Inhibit Lung Cancer Growth. Molecular Pharmacology. 82(6). 1115–1128. 64 indexed citations

16.

Yeh, Yu-Min, Yi-Lin Chen, Wu‐Chou Su, et al.. (2010). High Percentage of JAK2 Exon 12 Mutation in Asian Patients With Polycythemia Vera. American Journal of Clinical Pathology. 134(2). 266–270. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact